# Renji Hospital, Shanghai Jiao Tong University

Source: https://onco.cc/institutions/renji-hospital/  
OnCo record `renji-hospital` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Renji Hospital and the Shanghai Cancer Institute on its campus are where CARsgen's solid-tumour CAR-T work began, including the Claudin 18.2 CAR-T satri-cel for stomach cancer.

## Summary

Home of the State Key Laboratory of Oncogenes and Related Genes (Shanghai Cancer Institute), where Li Zonghai developed GPC3 and Claudin 18.2 CAR-T cells before founding CARsgen; a large gastrointestinal oncology and liver programme and one of the first sites for CT041 (satricabtagene autoleucel) trials.

## Fields

- Kind: Institution
- Last checked: 2026-09-10
- Also known as: Renji Hospital; 仁济医院; Shanghai Cancer Institute
- Tags: china
- City: Shanghai, CN
- Type: hospital
- Website: https://www.renji.com/

## Sources

- Official website: https://www.renji.com/

## Connected records

- cancers: [Gastric & gastro-oesophageal junction cancer](https://onco.cc/cancers/gastric/), [Hepatocellular carcinoma](https://onco.cc/cancers/hcc/)
- technologies: [CAR-T cell therapy](https://onco.cc/technologies/car-t/)
- drugs: [Satricabtagene autoleucel](https://onco.cc/drugs/satricabtagene-autoleucel/), [Zevorcabtagene autoleucel](https://onco.cc/drugs/zevorcabtagene-autoleucel/)
- companies: [CARsgen Therapeutics](https://onco.cc/companies/carsgen/)
- people: [Zonghai Li](https://onco.cc/people/li-zonghai/)

---
JSON: https://onco.cc/api/v1/entities/renji-hospital.json